CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy of Octreotide LAR in Acromegalic Patients.
Ji Youn Kim, Jae Hwan Jee, Chan Ho Yoon, Yun Jae Chung, Byung Wan Lee, Gun Yong Cho, Sang Young Kim, Jae Hoon Chung, Yong Ki Min, Myung Shik Lee, Moon Kyu Lee, Kwang Won Kim
Endocrinol Metab. 2005;20(4):344-352.   Published online August 1, 2005
DOI: https://doi.org/10.3803/jkes.2005.20.4.344

Excel Download

The efficacy of octreotide LAR in acromegalic patients as primary or secondary therapy
Therapeutic Advances in Endocrinology and Metabolism. 2012;3(1):3-9   Crossref logo
Link1 Link2 Link3

Octreotide LAR® treatment throughout pregnancy in an acromegalic woman
Clinical Endocrinology. 2001;55(3):411-415   Crossref logo
Link1 Link2 Link3

Efficacy of Octreotide LAR in Acromegalic Patients
Journal of Korean Society of Endocrinology. 2005;20(4):344   Crossref logo
Link1 Link2 Link3

Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR
Alimentary Pharmacology & Therapeutics. 2000;14(5):557-560   Crossref logo
Link1 Link2 Link3

Comparison of the Efficacy of Octreotide Long-acting Repeatable and Lanreotide Autogel in Acromegalic Patients
Journal of Korean Endocrine Society. 2010;25(1):25   Crossref logo
Link1 Link2 Link3

Comparison of the Efficacy of Octreotide Long-acting Repeatable and Lanreotide Autogel in Acromegalic Patients
Journal of Korean Endocrine Society. 2010;25(1):37   Crossref logo
Link1 Link2 Link3

Letter: Comparison of the Efficacy of Octreotide Long-acting Repeatable and Lanreotide Autogel in Acromegalic Patients (J Korean Endocr Soc 25:37-45, 2010)
Endocrinology and Metabolism. 2010;25(2):157   Crossref logo
Link1 Link2 Link3

6566 POSTER Updated Safety and Efficacy Results From RADIANT-2 – a Randomized, Double-blind, Multicenter, Phase III Trial of Everolimus + Octreotide LAR Vs Placebo + Octreotide LAR in Pts With Advanced Neuroendocrine Tumours (NET)
European Journal of Cancer. 2011;47:S461   Crossref logo
Link1 Link2

A comparison of lanreotide and octreotide LAR for treatment of acromegaly
Clinical Endocrinology. 1999;51(3):275-280   Crossref logo
Link1 Link2 Link3

Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR
Growth Hormone & IGF Research. 2010;20(2):87-92   Crossref logo
Link1 Link2